....those who chose gemcitabine-based chemotherapy survived more than three times as long (14.0 v 4.3 months) and had better quality of life than those who chose proteolytic enzyme treatment.
|
|
||
Pancreatic Proteolytic Enzyme Therapy Fails To Increase Survival or Quality of Life Compared to Conventional Gemcitabine Cytotoxic Therapy.....those who chose gemcitabine-based chemotherapy survived more than three times as long (14.0 v 4.3 months) and had better quality of life than those who chose proteolytic enzyme treatment. |
||
|
||
| Page 1 of 3 |